By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Markets > Stocks > Piper Sandler raises Olaplex to neutral, price target to $2 By Investing.com
Stocks

Piper Sandler raises Olaplex to neutral, price target to $2 By Investing.com

News Room
Last updated: 2024/04/13 at 12:50 AM
By News Room
Share
2 Min Read
SHARE

On Monday, Piper Sandler adjusted its stance on Olaplex Inc (NASDAQ:OLPX), elevating the stock from an Underweight to a Neutral rating, with the price target increased to $2.00 from the previous $1.25. The revision follows a series of surveys indicating a stabilization in the brand’s preference and penetration in salons, which have historically correlated with the company’s performance.

The firm’s decision to upgrade the rating is influenced by the observation that the previously bearish outlook, which included concerns over worsening trends and overly optimistic rebound expectations, may have played out. Recent data suggests that the downside risks are now more limited, presenting a balanced risk/reward scenario for investors.

Analysts noted that financial estimates for Olaplex have been revised downwards over the past quarters, with the Street’s 2024 estimated earnings per share now less than half of what was expected a year ago. This adjustment in expectations contributes to the firm’s enhanced confidence in the stock’s prospects.

In addition to the data from surveys, Piper Sandler has expressed satisfaction with the interactions with Olaplex’s new CEO, Amanda Baldwin. The CEO’s acknowledgment of the company’s historical challenges and her leadership are viewed as positive steps toward the company’s recovery.

The increase in the price target to $2.00 is based on a revised forward-looking EV/EBITDA multiple of approximately 9 times for fiscal year 2025, up from the prior multiple of around 6.5 times. This change reflects the firm’s increased confidence in Olaplex’s future financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.



Read the full article here

News Room April 13, 2024 April 13, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Mark Carney’s trial by G7 summit as ‘Godzilla’ comes to Canada

Canada’s Mark Carney will host world leaders in Kananaskis in coming days,…

Police manhunt continues for suspect in killing of Minnesota lawmaker and husband

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

American travel demand declines as US consumers cut costs

Stay informed with free updatesSimply sign up to the Travel & leisure…

Israel is achieving its goals in Iran — so far

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

The fallout from Israel’s strikes on Iranian energy sites

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Stocks

CPS reports solid 2023 performance, eyes future growth By Investing.com

By News Room
Stocks

Niu Technologies faces mixed results in Q4 2023 By Investing.com

By News Room
Stocks

Exagen Inc. reports strong 2023 revenue growth By Investing.com

By News Room
Stocks

Legacy Housing reports mixed results amid sales decline By Investing.com

By News Room
Stocks

Harmony Biosciences exec sells over $383k in stock By Investing.com

By News Room
Stocks

Biofrontera posts record revenue and outlines growth plans By Investing.com

By News Room
Stocks

Granite Ridge CFO buys $31,000 in company stock By Investing.com

By News Room
Stocks

Coliseum Capital Management buys MasterCraft Boat shares worth over $3.2m By Investing.com

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?